Recent multisociety practice guidelines have offered more clarity for clinicians who provide sedation outside the operating roomincluding dentists, endoscopists, and proceduralistswhen treating patients on GLP-1 receptor agonists (GLP-1 RAs) like Semaglutide, Ozempic, or Wegovy.sciencedirect Key Recommendations: Shared Decision-Making: Management should involve the patient and all relevant care teams (procedural, anesthesia, prescribing), considering metabolic needs and individual risk factors
Iso, T., Suzuki, T., Baird, L
IV injections are normally only given in clinics and hospitals
Semaglutide (Wegovy/Ozempic) activates only GLP-1 and produces roughly 15% weight loss at 68 weeks
[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Hoeflich A, Nedbal S, Blum WF, et al